Renovos Biologics Limited
Private Limited Company · Southampton
ActiveUnited KingdomIncorporated 2017Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2026-03-31
IXBRL · 129 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2026-03-31
IXBRL · 129 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2025-04-01 to 2026-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 86
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4272_10685524_20260331
- Source archive
- Accounts_Bulk_Data-2026-07-28.zip
Accounts to 2026-03-31
IXBRL · 129 source facts · 12 selected values
Validation findingsXBRL valid
Accounts to 2026-03-31
IXBRL · 129 source facts · 12 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-04-01 to 2026-03-31
- Extraction status
- complete
- Numeric facts
- 86
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2607_10685524_20260331
- Source archive
- Accounts_Monthly_Data-July2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2025-03-31
IXBRL · 137 source facts · 20 selected values
Validation findingsXBRL valid
Accounts to 2025-03-31
IXBRL · 137 source facts · 20 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- complete
- Numeric facts
- 96
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2508_10685524_20250331
- Source archive
- Accounts_Monthly_Data-August2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-03-31
IXBRL · 131 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 131 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 91
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2476_10685524_20240331
- Source archive
- Accounts_Monthly_Data-September2024.zip
Accounts to 2023-03-31
IXBRL · 129 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 129 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 90
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0022_10685524_20230331
- Source archive
- Accounts_Monthly_Data-August2023.zip
Accounts to 2022-03-31
IXBRL · 132 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 132 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 92
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0109_10685524_20220331
- Source archive
- Accounts_Monthly_Data-August2022.zip
Accounts to 2021-03-31
IXBRL · 130 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 130 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 89
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0098_10685524_20210331
- Source archive
- Accounts_Monthly_Data-December2021.zip
Accounts to 2020-03-31
IXBRL · 134 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 134 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2019-04-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 93
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0088_10685524_20200331
- Source archive
- Accounts_Monthly_Data-March2021.zip
Accounts to 2019-03-31
IXBRL · 106 source facts · 19 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 106 source facts · 19 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 69
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0073_10685524_20190331
- Source archive
- Accounts_Monthly_Data-December2019.zip
Accounts to 2018-03-31
IXBRL · 63 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2018-03-31
IXBRL · 63 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2017-03-22 to 2018-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 21
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0061_10685524_20180331
- Source archive
- Accounts_Monthly_Data-December2018.zip
Registered details
10685524- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2017-03-22
- Jurisdiction
- —
- Registered office
- 2 VENTURE ROAD, SOUTHAMPTON SCIENCE PARK, SOUTHAMPTON, SO16 7NP, UNITED KINGDOM
Classification
1 SIC codes23103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsPioneering Renovite nanoclay gels in cell therapyLeadActive
UKRI FLF · Fellowship · 2023-06-30 – 2027-06-29
£800,794
whole project
Renovite – regenerative nanoclay for orthobiologic applicationsLead
Innovate UK · Collaborative R&D · 2023-03-01 – 2025-03-31
£692,472
awarded
Developing an antimicrobial release strategy using nanoclay gels to treat osteomyelitisActiveMRC · Studentship · 2022-09-30 – 2027-09-29 · with 1 other participant£0whole project
Developing an antimicrobial release strategy using nanoclay gels to treat osteomyelitisActive
MRC · Studentship · 2022-09-30 – 2027-09-29 · with 1 other participant
£0
whole project
University of SouthamptonleadRenovos Biologics Limited
Renovite - pioneering use of synthetic nanoclays in regenerative medicineLeadInnovate UK · Study · 2020-11-01 – 2021-10-31 · with 1 other participant£101,404awarded
Renovite - pioneering use of synthetic nanoclays in regenerative medicineLead
Innovate UK · Study · 2020-11-01 – 2021-10-31 · with 1 other participant
£101,404
awarded
Renovos Biologics Limitedlead£101,404
University of Southampton£61,925
Harnessing Clay Gels for Bone Tissue RepairLeadInnovate UK · Collaborative R&D · 2017-11-01 – 2019-03-31 · with 1 other participant£195,460awarded
Harnessing Clay Gels for Bone Tissue RepairLead
Innovate UK · Collaborative R&D · 2017-11-01 – 2019-03-31 · with 1 other participant
£195,460
awarded
Renovos Biologics Limitedlead£195,460